Digestives & Intestinal Remedies - Eastern Europe

  • Eastern Europe
  • In Eastern Europe, the revenue in the Digestives & Intestinal Remedies market market is estimated to reach US$0.76bn in 2024.
  • It is projected to experience an annual growth rate of 2.74% (CAGR 2024-2029).
  • Comparing globally, in China generates the highest revenue in this market, amounting to US$4,408.00m in 2024.
  • When considering the population, the per person revenue in 2024 is US$3.18.
  • In Eastern Europe, the demand for digestive and intestinal remedies is on the rise as the population becomes more health-conscious.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Eastern Europe is experiencing steady growth due to various factors influencing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Eastern Europe are shifting towards natural and herbal remedies for digestive and intestinal issues. Consumers are becoming more health-conscious and are seeking products that are gentle on their bodies and have fewer side effects. This preference for natural remedies has led to an increase in the demand for herbal supplements and probiotics in the market. Additionally, consumers are also looking for products that provide long-term relief and promote overall digestive health.Trends in the market show a growing awareness and acceptance of alternative therapies and traditional medicine. Eastern European countries have a rich history of traditional medicine and herbal remedies, and consumers are increasingly turning to these remedies for digestive and intestinal issues. This trend is supported by the growing availability of traditional medicine products in pharmacies and health stores. Furthermore, there is a rising popularity of fermented foods and beverages, such as kefir and sauerkraut, which are known for their digestive benefits.Local special circumstances in Eastern Europe play a significant role in the development of the Digestives & Intestinal Remedies market. The region has a high prevalence of gastrointestinal disorders, including irritable bowel syndrome and gastritis. This has created a strong demand for products that alleviate symptoms and provide relief. Additionally, Eastern European countries have a well-established pharmaceutical industry, which enables the production and distribution of a wide range of digestive and intestinal remedies.Underlying macroeconomic factors in Eastern Europe are also contributing to the growth of the Digestives & Intestinal Remedies market. The region is experiencing economic growth, which has led to an increase in disposable income and improved standards of living. As a result, consumers are more willing to spend on healthcare products, including digestive and intestinal remedies. Furthermore, the aging population in Eastern Europe is driving the demand for digestive health products, as older individuals are more prone to digestive issues and are seeking solutions to improve their quality of life.In conclusion, the Digestives & Intestinal Remedies market in Eastern Europe is witnessing growth due to customer preferences for natural and herbal remedies, the trend towards alternative therapies and traditional medicine, local special circumstances such as a high prevalence of gastrointestinal disorders, and underlying macroeconomic factors including economic growth and an aging population. As the market continues to evolve, it is expected that there will be further advancements in product offerings and increased focus on digestive health in Eastern Europe.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)